Cochlear | COH - Les Charges D'Exploitation

Prix De L'Action
185.00
Variation Quotidienne
-0.83 -0.45%
Mensuellement
-26.05%
Annuel
-32.82%
Q1 Prévisions
191.63




Les Charges D'Exploitation Changement Date
Ansell USD 880.1M 465.65M 2025-12
Avita Medical AUD 28.02M 1.55M 2025-12
Cochlear AUD 914.9M 454.8M 2025-12
CSL USD 5.7B 2.82B 2025-12
Fisher Paykel Healthcare NZD 802.4M 24.1M 2025-12
Healius AUD 684.9M 261.2M 2024-12
Integral Diagnostics AUD 219.16M 66.76M 2024-06
Mayne Pharma AUD 103.54M 9.39M 2024-06
Mesoblast USD 56.15M 32.57M 2025-06
Monash IVF AUD 119.86M 61.99M 2025-12
Nanosonics AUD 93.11M 45.89M 2025-12
Polynovo AUD 27.51M 19.08M 2024-06
Ramsay Health Care AUD 8.8B 83.5M 2025-12
Regis Healthcare AUD 643.07M 113.42M 2025-12
ResMed USD 922.51M 49.28M 2025-12
Sigma Healthcare AUD 1.68B 174.89M 2024-12
Somnomed AUD 47.82M 4.98M 2023-06
Sonic Healthcare AUD 4.23B 2.14B 2024-12
Telix Pharmaceuticals AUD 405.4M 26.29M 2025-12